Growth Passive

iShares MSCI EAFE Growth ETF

The iShares MSCI EAFE Growth ETF (the “Fund”) seeks to track the investment results of an index composed of developed market equities, excluding the U.S. and Canada, that exhibit growth characteristics.

$121.08

Key Metrics

TER 0.34% per year
Distribution policy Distributing
Fund size USD 16,597 M
Inception date July 31, 2005
Holdings 376
Fund currency USD
Fund domicile US
Provider iShares
For full official fund details, factsheets, and holdings, visit ishares.com (opens in new tab).

Compare similar ETFs

Fund Size
Dividend
Fees
Current
MSCI EAFE Growth ETF EFG
Fund Size
$16.7B
Dividend
2.3%
Fees
0.34%
Morningstar Growth Index Fund VUG
Fund Size
$380B
Dividend
0.4%
Fees
0.03%
Russell 1000 Growth ETF IWF
Fund Size
$130B
Dividend
0.3%
Fees
0.18%
S&P 500 Growth ETF IVW
Fund Size
$75.1B
Dividend
0.3%
Fees
0.18%
Schwab U.S. Large-Cap Growth ETF SCHG
Fund Size
$61.1B
Dividend
0.4%
Fees
0.04%
View 117 similar ETFs →

Historical Return

Last updated: Oct 01, 2026
1 Year +4.2% +2.3% Div
3 Years (avg.) +12.1% +2.3% Div
5 Years (avg.) +2.3% +2.3% Div

Risk & Analysis Metrics

Last updated: Oct 01, 2026

Volatility

17.68% 1 Year
16.73% 3 Years
18.24% 5 Years
17.55% 10 Years

Max Drawdown

-12.81% 1 Year
-17.44% 3 Years
-36.62% 5 Years
-36.90% 10 Years

Sharpe Ratio

0.05 1 Year
0.48 3 Years
-0.02 5 Years
0.16 10 Years

Return Triangle (Heatmap)

Last updated: Oct 01, 2026
2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
2011 -15.5% -2.8% 3.5% 1.0% 1.2% 0.4% 3.8% 1.3% 3.7% 4.9% 5.2% 2.4% 3.3% 3.2% 4.1%
2012 11.8% 14.5% 7.2% 5.9% 3.9% 7.4% 3.9% 6.4% 7.4% 7.5% 4.2% 5.0% 4.8% 5.6%
2013 17.2% 4.9% 4.0% 2.0% 6.5% 2.6% 5.7% 6.9% 7.1% 3.4% 4.4% 4.2% 5.2%
2014 -6.2% -2.1% -2.6% 4.0% -0.1% 3.9% 5.5% 5.9% 2.0% 3.2% 3.1% 4.2%
2015 2.2% -0.7% 7.6% 1.5% 6.0% 7.6% 7.7% 3.1% 4.3% 4.0% 5.2%
2016 -3.6% 10.5% 1.3% 7.0% 8.7% 8.7% 3.2% 4.6% 4.3% 5.5%
2017 26.6% 3.9% 10.7% 12.0% 11.3% 4.4% 5.8% 5.3% 6.6%
2018 -14.8% 3.6% 7.5% 7.8% 0.4% 2.7% 2.5% 4.4%
2019 25.9% 20.8% 16.5% 4.6% 6.6% 5.8% 7.4%
2020 15.9% 12.1% -1.6% 2.3% 2.1% 4.6%
2021 8.5% -9.3% -1.9% -1.0% 2.5%
2022 -24.2% -6.7% -4.0% 1.1%
2023 14.8% 8.0% 11.2%
2024 1.6% 9.5%
2025 18.0%

Distributions

*by ETF Portfolio Weight Last updated: Oct 01, 2026

Profit Margin Distribution

< 0%
2%
1y 3y N/A N/A
0 - 5%
4%
1y 3y N/A N/A
5 - 10%
23%
1y 3y N/A N/A
10 - 15%
12%
1y 3y N/A N/A
15 - 20%
9%
1y 3y N/A N/A
20 - 30%
38%
1y 3y N/A N/A
30 - 40%
6%
1y 3y N/A N/A
> 40%
5%
1y 3y N/A N/A

P/E Ratio Distribution

< 0
2%
1y 3y N/A N/A
0 - 10
9%
1y 3y N/A N/A
10 - 15
6%
1y 3y N/A N/A
15 - 20
10%
1y 3y N/A N/A
20 - 25
20%
1y 3y N/A N/A
25 - 35
21%
1y 3y N/A N/A
35 - 50
11%
1y 3y N/A N/A
> 50
22%
1y 3y N/A N/A

Discounted Cash Flow

Weighted Average Undervaluation
N/A
Undervalued
> 60%
0%
1y 3y N/A N/A
45 - 60%
0%
1y 3y N/A N/A
30 - 45%
0%
1y 3y N/A N/A
15 - 30%
0%
1y 3y N/A N/A
Fair (&plusmn;15%)
0%
1y 3y N/A N/A
Overvalued
15 - 30%
0%
1y 3y N/A N/A
30 - 45%
0%
1y 3y N/A N/A
45 - 60%
0%
1y 3y N/A N/A
> 60%
0%
1y 3y N/A N/A

Market Cap Size Distribution

Micro Cap
0.0%
1y 3y N/A N/A
Small Cap
0.0%
1y 3y N/A N/A
Mid Cap
0.7%
1y 3y N/A N/A
Large Cap
62.4%
1y 3y N/A N/A
Mega Cap
36.8%
1y 3y N/A N/A
Micro: < $300M Small: $300M–$2B Mid: $2B–$10B Large: $10B–$200B Mega: > $200B

Portfolio Concentration

*by ETF Portfolio Weight Last updated: Oct 01, 2026
38.7% Top 5 Holdings
57.2% Top 10 Holdings
97.8% Top 50 Holdings
100.0% Top 100 Holdings
Top 5 Companies
ASML ASML Holding NV
14.7%
AZN AstraZeneca Plc
7.7%
NVS Novartis AG
7.4%
SAP Sap SE
4.6%
SMEGF Siemens Energy AG
4.3%

Latest News

27 days ago • benzinga.com

Novartis Myotonic Dystrophy Trial Flop Sends Dyne Therapeutics Shares Tumbling

Dyne Therapeutics Inc. (NASDAQ:DYN) stock is trading lower on Tuesday in reaction to Novartis AG's (NYSE:NVS) data from the global Phase 3 HARBOR s...

27 days ago • 247wallst.com

Amgen Falls 10% as Novartis Trial Failure Clouds a Cholesterol Drug Class; NVS Stock Drops 14%

A failed cholesterol trial from Novartis (NYSE:NVS | NVS Price Prediction) is dragging the Lp(a) drug class lower and hitting Amgen (NASDAQ:AMGN) h...

27 days ago • reuters.com

Dyne, Sarepta shares tumble as Novartis setback weighs on muscle disease drug developers

Shares of Dyne Therapeutics and Sarepta slumped on Tuesday after Novartis' treatment for a muscle-wasting disorder failed in a trial, fueling inves...

Average metrics of all companies in portfolio

Last updated: Oct 04, 2026
Market
Average
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $225B -
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 1.51% 2.02%
Beta Indicates the relationship between the price performance of a share and the market. 0.84 -
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 31.69 23.08
Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything -100.95 -
Profitable Companies 97% -
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 34.13 19.24
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 5.95 9.85
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 8.58 12.6
Market
Average
Enterprise Value to EBIT Enterprise Value divided by EBIT 23.76 11.97
Enterprise Value to Revenue Enterprise value divided by revenue 6.63 13.3
Total Debt to Enterprise Value Total debt divided by enterprise value 0.27 0.04
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. 0.89 0.32
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. 18.15% 21.62%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. +24.1% +55.1%
Return on Equity Equity divided by market cap. 24.96% 1.73%
Return on Assets Indicates a company's profitability in relation to its total assets. 10.11% 3.97%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. 20.33% 3.60%

Sectors

Manufacturing 17.9%
Health Technology 4.6%
Information 4.5%
Finance and Insurance 4.1%
Finance 1.8%
Producer Manufacturing 1.2%
Mining, Quarrying, and Oil and Gas Extraction 0.9%
Professional, Scientific, and Technical Services 0.7%
Retail Trade 0.6%
Consumer Non-Durables 0.4%
Technology 0.4%
Industrials 0.4%
Administrative and Support and Waste Management and Remediation Services 0.3%
Healthcare 0.3%
Transportation and Warehousing 0.2%
Electronic Technology 0.1%
Other 61.4%

Countries

Japan 24.6%
United Kingdom 11.3%
Netherlands 10.6%
Switzerland 10.3%
Germany 8.8%
France 7.6%
Australia 6.5%
Sweden 5.1%
Denmark 2.5%
Spain 2.2%
Hong Kong 2.0%
Singapore 1.6%
Italy 1.6%
Israel 1.2%
Belgium 1.1%
Finland 0.8%
Ireland 0.6%
Norway 0.4%
Austria 0.3%
New Zealand 0.3%
Luxembourg 0.2%
Portugal 0.2%
Other 0.1%
China 0.1%
Mexico 0.1%
Macao 0.0%
United States 0.0%
Other 0.0%

Stock Screener

Select filters to narrow down the 72 investments below

72 companies

Limit holdings to companies in a single sector.

$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%
Market Cap $719.69B
P/E Ratio 60.0
Dividends 0.5%
Total Investment $983.24M
Weight 5.92%

Loading details…

Market Cap $294.4B
P/E Ratio 23.4
Dividends 2.0%
Total Investment $395.51M
Weight 2.38%

Loading details…

Market Cap $243.03B
P/E Ratio 26.8
Dividends 1.4%
Total Investment $293.87M
Weight 1.77%

Loading details…

Market Cap $156.38B
P/E Ratio 16.0
Dividends 2.2%
Total Investment $258.13M
Weight 1.56%

Loading details…

Market Cap $69.02B
P/E Ratio 35.7
Dividends 1.1%
Total Investment $237.71M
Weight 1.43%

Loading details…

Market Cap $165.72B
P/E Ratio 9.5
Dividends 4.7%
Total Investment $234.28M
Weight 1.41%

Loading details…

Market Cap $159.69B
P/E Ratio 31.2
Dividends 1.0%
Total Investment $222.77M
Weight 1.34%

Loading details…

Market Cap $169.25B
P/E Ratio 25.2
Dividends 1.7%
Total Investment $214.49M
Weight 1.29%

Loading details…

Market Cap $139.88B
P/E Ratio -102.1
Dividends 0.8%
Total Investment $209.91M
Weight 1.26%

Loading details…

Market Cap $146.34B
P/E Ratio 46.2
Dividends 0.5%
Total Investment $203.65M
Weight 1.23%

Loading details…

Market Cap $91.28B
P/E Ratio 11.6
Dividends 2.9%
Total Investment $165.82M
Weight 1.00%

Loading details…

Market Cap $334.58B
P/E Ratio 22.5
Dividends 2.8%
Total Investment $165.31M
Weight 1.00%

Loading details…

Market Cap $145.51B
P/E Ratio 14.8
Dividends 3.8%
Total Investment $162.93M
Weight 0.98%

Loading details…

Market Cap $94.22B
P/E Ratio 14.8
Dividends 3.8%
Total Investment $162.13M
Weight 0.98%

Loading details…

Market Cap $268B
P/E Ratio 21.3
Dividends 3.2%
Total Investment $153.95M
Weight 0.93%

Loading details…

Market Cap $95.15B
P/E Ratio 70.3
Dividends 0.5%
Total Investment $144.09M
Weight 0.87%

Loading details…

Market Cap $144.62B
P/E Ratio 12.3
Dividends 1.8%
Total Investment $120.11M
Weight 0.72%

Loading details…

Loading details…

Market Cap $196.1B
P/E Ratio 10.6
Dividends 2.0%
Total Investment $109.73M
Weight 0.66%

Loading details…

Market Cap $69.82B
P/E Ratio 25.4
Dividends 1.1%
Total Investment $105.35M
Weight 0.63%

Loading details…